Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 14 at 2:00 PM EDT

Register Free →

LANTHEUS MEDICAL IMAGING, INC.

Subsidiary ofLANTHEUS HOLDINGS, INC.UEI: ZBTPKVDXCKJ7CAGE: 1YCS9

LANTHEUS MEDICAL IMAGING, INC. is a federal contractor, registered under UEI ZBTPKVDXCKJ7 and CAGE code 1YCS9. It has been awarded $35,540,972 across 3,528 federal contracts. Primary work spans Pharmaceutical Preparation Manufacturing, Unknown NAICS, and Other NAICS codes (13 codes, <0.5% each). Top awarding agencies include Department Of Veterans Affairs, Department Of Defense, and Department Of Health And Human Services.

Contact Information

Registration and classification details

Registration

UEI Code

ZBTPKVDXCKJ7

CAGE Code

1YCS9

Entity Structure

Corporate Entity (Not Tax Exempt)

Established

N/A

Business Classifications

For Profit OrganizationManufacturer of Goods

NAICS Codes

325412Pharmaceutical Preparation Manufacturing(Primary)

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

Lantheus Medical Imaging, Inc. specializes in the manufacturing and supply of radiopharmaceuticals and technetium-99m generator systems for nuclear medicine applications in military and veteran healthcare settings. Their core capabilities center on the production of diagnostic radiopharmaceuticals, ...

Lantheus Medical Imaging, Inc. specializes in the manufacturing and supply of radiopharmaceuticals and technetium-99m generator systems for nuclear medicine applications in military and veteran healthcare settings. Their core capabilities center on the production of diagnostic radiopharmaceuticals, including Mo-99/Tc-99m generators, which enable critical imaging procedures such as cardiac, oncologic, and skeletal scans. The company demonstrates deep technical expertise in radiopharmaceutical logistics, isotope delivery timelines, and cold kit formulation compliant with FDA and nuclear regulatory standards. Their differentiation lies in reliable, just-in-time delivery of short-lived isotopes to remote and high-demand military medical centers, ensuring uninterrupted diagnostic capabilities in deployed and garrison environments. The contractor maintains a consistent relationship with the Department of Defense, supplying radiopharmaceuticals and generator systems to major Army medical centers including Dwight D. Eisenhower Army Medical Center, Tripler Army Medical Center, and William Beaumont Army Medical Center. These engagements reflect a trusted partnership in sustaining nuclear medicine operations across the Defense Health Agency’s network. A single award with the Department of Veterans Affairs indicates similar support for veteran healthcare imaging needs. Lantheus operates primarily under NAICS 325412, which encompasses pharmaceutical preparation manufacturing with a focus on radiopharmaceuticals. This positions them as a niche supplier within the defense and federal healthcare sectors, serving specialized diagnostic imaging markets that require precise isotopic purity, regulatory compliance, and cold chain integrity. Their market positioning is defined by technical precision in nuclear medicine supply chains rather than broad pharmaceutical distribution. As a 2L entity headquartered in North Billerica, Massachusetts, Lantheus Medical Imaging, Inc. is a mid-sized manufacturer with no government certifications on record. Their geographic presence is centered in the Northeast, with federal operations extending nationwide to support DoD and VA medical facilities through dedicated logistics networks for radiopharmaceutical distribution.

Key Performance Metrics

Awards Count

0

All time

Active

0

Currently performing

Completed

0

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency
Awards by NAICS
325412 - Pharmaceutical Preparation Manufacturing$33.0M92.9%
- Unknown NAICS$1.9M5.4%
Others - Other NAICS codes (13 codes, <0.5% each)$610.6K1.7%
Awards by Agency Over Time
Awards by Place of Performance

Compete with LANTHEUS MEDICAL IMAGING, INC.

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for LANTHEUS MEDICAL IMAGING, INC.

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS

Open opportunities in LANTHEUS MEDICAL IMAGING, INC.'s top NAICS codes and agencies

NAICS: 325412
New
Federal
6505--Latanoprost Ophthalmic Solution (VA-27-00006027)
Solicitation # 36E79727R0039
The Department of Veterans Affairs Enterprise Procurement Office is initiating an unrestricted procurement under solicitation 36E79727R0039 for Latanoprost Ophthalmic Solution. This acquisition aims to establish an uninterrupted source of supply for the VA, including Consolidated Mail Order Pharmacies and Option 2 State Veterans Homes, as well as the Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Centers. The contract will be awarded to a single responsible offeror for a base period of one year with four pre-priced one-year option periods. Distribution will be managed through the respective Pharmaceutical Prime Vendor Programs of the VA and DoD. The procurement is issued in commercial item format per FAR Part 12 under NAICS code 325412 and is subject to the World Trade Organization Government Procurement Agreement and Free Trade Agreements. Strict labeling requirements are in place, requiring offerors to provide a unique NDC number and the exact drug name as it appears on the label. The contractor's label must be the sole label on the product, cannot be affixed over another label, and must allow VA labels to adhere securely on top. Additionally, vendors must comply with the American Academy of Ophthalmology’s uniform color-coding system for caps and labels. The solicitation is expected to be issued around October 21, 2026, with a tentative closing date of November 4, 2026, though some metadata indicates a response deadline of October 16, 2026.
Nac Pharmaceuticals (36E797)

POSTED

about 23 hours ago

DEADLINE

in 13 days
View Details